BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-04-30

Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-30	Common Stock	A	338	$62.586	Acquired	63402	Direct
2020-06-19	Common Stock	M	15000	$63.100	Acquired	78402	Direct
2020-06-19	Common Stock	S	15000	$124.00	Disposed	63402	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-19	Stock Option (Right to buy Common Stock)	$63.100	M	15000	Disposed	2024-06-03	Common Stock (15000)	Direct

F1: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.